Literature DB >> 10027571

Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.

R D Leslie1, M A Atkinson, A L Notkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10027571     DOI： 10.1007/s001250051105

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  35 in total

1.  Autoantibodies as predictors of disease.

Authors:  D Leslie; P Lipsky; A L Notkins
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Early induction of type 1 diabetes.

Authors:  M I Hawa; R D Leslie
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

3.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 4.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

Review 5.  GAD antigen and its significance in type I diabetes.

Authors:  M I Hawa; R D G Leslie
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 6.  Autoimmune diabetes: more than just one flavor?

Authors:  H K Chiu; J P Palmer
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

7.  Inducible expression in plants by virus-mediated transgene activation.

Authors:  Anna K Hull; Vidadi Yusibov; Vadim Mett
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

Review 8.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

9.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

10.  A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).

Authors:  Paul G Drake; Günther H Peters; Henrik Sune Andersen; Wiljan Hendriks; Niels Peter H Møller
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.